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Introduction
This paper focuses on the creation and delivery of ambulatory care pharmacy services in hospital or health-system settings and discusses how to integrate those services with the mission and operations of the entire institution. Also covered are opportunities for ambulatory care pharmacists to help hospitals and health systems meet current challenges in expanding access to care; improving quality, continuity, and outcomes of care; lowering the cost of care; and optimizing payment for care.
Practical considerations in establishing a new ambulatory care pharmacy service
Because of new financial incentives to improve the continuity of care, a growing number of hospitals and health systems will be establishing or expanding ambulatory care pharmacist services.
1 Although pharmacists are well-versed in the therapeutic management of chronic diseases and have extensive training in evidence-based pharmacotherapy, they have little formal training in how to implement and manage an ambulatory care service. The importance of knowledge in practice management is evidenced by the fact that 20% of the Ambulatory Care Pharmacy Specialty Certification Examination by the Board of Pharmacy Specialties is devoted to this domain. 2 What follows is a brief overview of the steps involved in implementing ambulatory care pharmacist services. Some of these points are covered in more detail in other briefing papers for the ASHP Ambulatory Care Conference and Summit.
(1) Conduct a needs assessment. The first step in establishing a new patient care service is to perform a needs assessment. Health systems should identify patients who are at greatest risk for adverse medication-related outcomes (because of the complexity of their therapy, for example) or high resource utilization or those with chronic disease associated with 3 significant morbidity and mortality. Example patient populations who would benefit from comprehensive ambulatory care pharmacy services include those with chronic obstructive pulmonary disease (COPD), heart failure, diabetes, and coronary artery disease, and those requiring anticoagulation. Conditions such as these are the focus of efforts by the Centers for
Medicare & Medicaid Services (CMS) to reduce hospital readmission rates and can be the target of pharmacy interventions that will most likely be supported by health-system administrators.
Transitional care programs also represent a significant opportunity for the development of ambulatory care pharmacy services, as discussed elsewhere in this paper.
The "drug therapy management complexity score" that is being developed and validated by the ASHP Research and Education Foundation might have utility in future needs assessment for ambulatory care pharmacy services. 3 (2) Align goals with organizational mission and objectives. The mission and vision for the program should support the health system's mission and vision, and the goals of the proposed service should align with the goals of the parent organization. This alignment will improve the potential for approval of the service. 4 Prepare a business plan that explains how the proposed program supports the mission, vision, philosophy, and strategic objectives of the organization. As the health care system continues to evolve and the need for team-based care increases, expansion of pharmacists' scope of practice to include prescribing will be necessary to optimize medication-related outcomes for patients across the continuum of care. provide direct patient care services and to participate in outcomes research. The use of students and residents can greatly increase the capacity to accept new patients and has been shown to improve patient education rates and decrease hospital readmissions. 15 Estimate additional nonpersonnel resources needed to provide the service such as point-of-care devices, alcohol pads, cotton balls, lancet devices, bandages, office supplies, and information technology. area you will target for your service (e.g., pulmonology, hematology, cardiology) and gain their buy-in. In addition, identify nonphysician personnel that will be involved in the service (nurses, laboratory personnel, registration staff) and educate them on their role in the service. Monitoring economic outcomes is imperative for the success of the service. Although generating revenue to cover costs and create margin is optimal, cost-avoidance and shared revenue models are equally important. 18 As part of assuming a responsible role in an integrated care-delivery model, pharmacy services may also share in penalties associated with failure to prevent high resource utilization and readmission.
Measure humanistic outcomes such as patient and provider satisfaction and quality of life. 19 Although rarely reported, patient quality of life should ultimately improve as a result of participation in your service. Periodically conduct validated satisfaction surveys to measure the perceived value of your service. Patient and provider satisfaction is an extremely valuable marker of success and can be used as a marketing tool to increase referrals and enhance support of executive and clinical leaders in the organization.
Opportunities related to patient-centered medical homes
The joint principles of the patient-centered medical home (PCMH) promote physician-led coordination of patients' health care needs and an integrated team approach to providing patientcentered care. 20 Pharmacists in the PCMH model can optimize the use of medications by identifying, resolving, and preventing medication-related problems before they occur, and they can help achieve better outcomes through provision of comprehensive medication management as part of a fully-integrated patient care delivery team.
As summarized by Smith et al., 21 approximately 32% of adverse events leading to hospital admission are attributed to medications; drug interactions are a major contributing factor in medication misadventures at home; and adherence rates to medication regimens for chronic disease are consistently low, averaging approximately 33% to 50%.
Smith et al. summarized the role of pharmacists in the medical home as follows:
As a clinical expert working in an interdisciplinary primary care team, a pharmacist can assess whether medication use by patients at home (in between primary care office visits) is contributing to medication-related problems or failure to achieve desirable outcomes. Although pharmacists are seldom mentioned in medical home discussions, the complementary knowledge and skills of pharmacists and prescribers can lead to improved patient care and medication use-especially for chronic conditions. 21 Choe et al. reported the development of a "reproducible model" for pharmacist engagement in the PCMH at the University of Michigan, which involved eight general medical practice sites. 22 The pharmacists' primary role in this medical home was "to evaluate and optimize therapeutic regimens to achieve treatment goals for diabetes, hypertension, hyperlipidemia, and polypharmacy." Among the patients who were referred to pharmacists, nearly half were experiencing more than one uncontrolled condition.
At a federally qualified health center in Connecticut, where a pharmacy practitionereducator received referrals from primary care providers to address medication-related problems, the most common issues addressed by the pharmacist stemmed from poor medication adherence (47% of the problems) and the need for additional therapy (24%). 21 Among unanswered questions identified by Smith et al. related to pharmacist engagement in PCMHs were (1) how to identify patients for pharmacist services, (2) giving pharmacists complete access to patient information, and (3) payment reform to support a sustainable role for pharmacists. 21 These issues are particularly vexing for practitioners in a community pharmacy setting.
The American Medical Association (AMA), in developing Current Procedural Terminology (CPT) codes for medication management services, identified the following five elements of comprehensive medication management in the medical home 23 :
1. The service (medication management) needs to be delivered directly to a specific patient. 2. The service must include an assessment of the specific patient's medication-related needs to determine if the patient is experiencing any drug therapy problems. In addition, a care plan is developed to resolve the problems, establish specific therapy goals, implement personalized interventions and education, and follow up to determine the actual outcomes the patient experienced from taking the medications. 3. The care must be comprehensive because any medication affects all other medications and all medical conditions. 4. The work of pharmacists and medication therapy practitioners needs to be coordinated with other team members in the PCMH. 5. The service is expected to add unique value to the care of the patient. Table 1 on the next page). 24 This delineation highlights the inherent professional opportunities for pharmacists within the PCMH. Drug therapy problems are identified, resolved, and prevented in a systematic and comprehensive manner so everyone is working most effectively to realize appropriate, effective, safe, and convenient drug therapy for the patient. Expanded Access to Care Enhanced access to care is available.
Physicians are extended and made more efficient and effective through the optimal management of a patient's medications.
Recognition of Added Value
Payment of physician practices appropriately recognizes added value.
Clinical outcomes are improved, ROI is positive, acceptance by patients is high, and physicians support the practice.
Opportunities related to accountable care organizations
While the PCMH model is intended to coordinate care among physicians and other patient care professionals, the goals of accountable care organizations (ACOs) are broader and include coordination along the continuum of health care delivery, from physician to hospital to other clinicians and nonclinicians. 25 In March of 2011, CMS proposed rules for the formation of ACOs for Medicare beneficiaries which aim to achieve (1) better care for individuals, (2) better health for populations, and (3) lower growth in expenditures by eliminating waste and inefficiencies.
Providers in the ACO can be rewarded for improved care coordination; they also are subjected to financial penalties for poor performance, depending on the structure of the ACO. 25 The PCMH can contribute to the success of ACOs by helping decrease hospitalizations, rehospitalizations, and emergency department visits. Improved care coordination and communication among health care practitioners and the development of an efficient primary care network are necessary to achieve these objectives.
Several models of pharmacists' integration into primary care networks currently exist and support the overarching goals of ACOs. Smith et al. 26 recently described different levels of pharmacists' collaboration with providers in primary care. They pointed out that the scope of ambulatory care pharmacy services varies greatly from minimal collaboration (in which pharmacists work mainly in a pharmacy setting and have limited communication with primary care office staff) to full collaboration (in which pharmacists enter into collaborative practice with providers and accept referrals to perform well-defined services such as medication reconciliation, medication management, and coordination or follow-up across multiple prescribers and pharmacies). To be fully integrated into primary care networks within the ACO model, pharmacists must strive to achieve this higher level of collaboration.
Smith et al. 26 described four models for integrating pharmacists into accountable care organizations:
1. Employing the pharmacist as a clinician staff member of a large group practice or an integrated delivery system. 2. Embedding the pharmacist in a practice site through a partnership between the practice and a health-system pharmacy or college of pharmacy. 3. Employing the pharmacist (through a health system or physician organization) to serve several practices in a geographic region. 4. Contracting with the pharmacist to provide services for specific patients in a shared resource network model.
Among the challenges associated with full integration of pharmacy services are practicelevel considerations (e.g., the need to restructure office work flow to maximize efficient use of pharmacists), the need for patient care quality measures associated with medication management, and the need for payment reform at the policy and practice level. 25 The current reimbursement environment does not offer sufficient incentives for medication management of complex patients and provision and support of wellness initiatives.
The ASHP Task Force on Accountable Care Organizations published a comprehensive report in January 2013 on how to integrate the services of health-system pharmacists into ACOs. 27 The following challenges and opportunities related to pharmacist engagement in ACOs were discussed in the report:
1. Prioritizing patients for pharmacy services, 2. Measuring pharmacists' quality and financial impact, 3. Communicating with patients and influencing patient behavior, 4. Addressing formulary limitations and prior-authorization requirements, 5. Dealing with specialized pharmacies and restricted drug distribution systems, and 6. Collaborating with pharmacists and other health care professionals outside of health systems.
Opportunities related to immunization
Exercising pharmacist responsibility for patient outcomes must include preventive care and wellness programs. The provision of immunization against diseases such as influenza and pneumococcal disease can have a profound impact on health outcomes and should be an integral component to promoting wellness. Pharmacists in all 50 states have authority to administer immunization. In addition, CMS no longer requires a physician order for pneumococcal and influenza vaccination in participating hospitals, long-term care facilities, and home care facilities, which presents an important opportunity for health-system pharmacists. Collaborative practice agreements, utilization of standardized order sets, and heightened awareness and education of health care professionals and patients have been shown to increase immunization rates and subsequently decreased morbidity associated with preventable diseases. 28 Despite the widespread ability to participate in immunization programs, pharmacists remain an underutilized resource in decreasing morbidity and mortality from preventable diseases.
Opportunities related to wellness initiatives
As of January 1, 2011, the Affordable Care Act provides for an Annual Wellness Visit (AWV), including Personalized Prevention Plan Services (PPPS) for Medicare beneficiaries. 29 The initial AWV consists of the following components: 
Identifying and overcoming challenges
Among the current imperatives facing pharmacy are integration of pharmacist services into team-based care and expansion of ambulatory care practice to optimize medication-related outcomes and establish the pharmacist as an integral member of the patient care team. The following challenges must be addressed in order to achieve these imperatives. To address the need for further development of an HIT infrastructure that supports integration of pharmacy services, the Pharmacy Health Information Technology Collaborative (www.pharmacyhit.org) created a strategic plan for the use of pharmacy HIT. 35 The focus of the Collaborative is to assure the meaningful use of a standardized electronic health record (EHR) to support safe, efficient, and effective medication use, continuity of care, and access to the patient care services of pharmacists with other members of the interdisciplinary patient care team. The
Mechanisms for communication.
Collaborative seeks to assure that the pharmacist's role of providing patient--care services is integrated into the national health IT interoperable framework. It has identified 10 goals for pharmacy HIT (see Table 2 below). Reimbursement models need to adapt to the changing health care environment.
Contracting with health systems under a shared revenue/shared risk model may be the focus of future reimbursement strategies for ambulatory care pharmacy programs. Compensation for services may be linked to patient outcomes and not based solely upon the fact that a service was provided.
Conclusion
It is an exciting time to be an ambulatory care pharmacist. As we embrace the changing face of health care brought about by the Affordable Care Act, so too must we embrace the responsibilities bestowed upon us as primary providers of medication management. Ambulatory care pharmacists must continue to expand their scope of practice to promote appropriate medication use, provide patient-centered care, focus attention on prevention and wellness, foster integration into the health care delivery team, and assume increased responsibility for patient outcomes. As a profession, we must continue efforts to enhance collaboration with other health care professionals with the goal of improving patient outcomes. We must advocate for the pursuit of provider status to ensure recognition and compensation for our services while exploring new opportunities to share in revenue generated by improved patient outcomes and decreased resource utilization.
To ensure their acceptance as an essential component of patient care delivery, ambulatory care pharmacists must become forceful instruments of constructive change in the evolving health care environment.
